These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31584632)

  • 1. Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection.
    White NC; Mendo-Lopez R; Papamichael K; Cuddemi CA; Barrett C; Daugherty K; Pollock N; Kelly CP; Alonso CD
    Clin Infect Dis; 2020 Sep; 71(6):1472-1478. PubMed ID: 31584632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
    Mulherin DW; Hutchison AM; Thomas GJ; Hansen RA; Childress DT
    Infection; 2014 Dec; 42(6):999-1005. PubMed ID: 25129565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
    Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):755-757. PubMed ID: 34492699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):e1029-e1044. PubMed ID: 34164674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
    Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
    mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a best practice alert to reduce unnecessary Clostridium difficile testing following receipt of a laxative.
    Bilinskaya A; Goodlet KJ; Nailor MD
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):50-55. PubMed ID: 29779649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
    Patel I; Wungjiranirun M; Theethira T; Villafuerte-Galvez J; Castillo N; Akbari M; Alonso CD; Leffler DA; Kelly CP
    J Antimicrob Chemother; 2017 Feb; 72(2):574-581. PubMed ID: 28115504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline stool toxin concentration is associated with risk of recurrence in children with
    Sandora TJ; Kociolek LK; Williams DN; Daugherty K; Geer C; Cuddemi C; Chen X; Xu H; Savage TJ; Banz A; Garey KW; Gonzales-Luna AJ; Kelly CP; Pollock NR
    Infect Control Hosp Epidemiol; 2023 Sep; 44(9):1403-1409. PubMed ID: 36624698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
    Dubberke ER; Reske KA; Hink T; Kwon JH; Cass C; Bongu J; Burnham CD; Henderson JP
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1330-1333. PubMed ID: 30226126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection.
    Alonso CD; Kelly CP; Garey KW; Gonzales-Luna AJ; Williams D; Daugherty K; Cuddemi C; Villafuerte-Gálvez J; White NC; Chen X; Xu H; Sprague R; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2022 Jul; 74(12):2142-2149. PubMed ID: 34537841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with
    Stevens VW; Shoemaker HE; Jones MM; Jones BE; Nelson RE; Khader K; Samore MH; Rubin MA
    Infect Control Hosp Epidemiol; 2020 May; 41(5):510-516. PubMed ID: 31996280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review on the definition and predictors of severe Clostridiodes difficile infection.
    Zhang VRY; Woo ASJ; Scaduto C; Cruz MTK; Tan YY; Du H; Feng M; Siah KTH
    J Gastroenterol Hepatol; 2021 Jan; 36(1):89-104. PubMed ID: 32424877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.
    Perry DA; Shirley D; Micic D; Patel PC; Putler R; Menon A; Young VB; Rao K
    Clin Infect Dis; 2022 Jun; 74(11):2028-2035. PubMed ID: 34459885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
    Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
    Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Therapies for Clostridioides difficile Infection in Children.
    Gonzales-Luna AJ; Carlson TJ; Garey KW
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laxative use and testing for Clostridium difficile in hospitalized adults: An opportunity to improve diagnostic stewardship.
    Carter KA; Malani AN
    Am J Infect Control; 2019 Feb; 47(2):170-174. PubMed ID: 30301657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.